Sanders Morris Harris’s BeOne Medicines Ltd ONC Stock Holding History

Sanders Morris Harris’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,700	Closed	-$802K	–	294
2026 Q1	$802K	Buy	+2,700	New	+$874K	0.13%	140
2025 Q4	–	Sell	-2,700	Closed	-$920K	–	308
2025 Q3	$920K	Buy	+2,700	New	+$820K	0.12%	117
2025 Q2	–	Sell	-2,700	Closed	-$732K	–	309
2025 Q1	$732K	Hold	2,700	–	–	0.11%	121
2024 Q4	$499K	Hold	2,700	–	–	0.07%	163
2024 Q3	$606K	Hold	2,700	–	–	0.1%	140
2024 Q2	$385K	Hold	2,700	–	–	0.06%	186
2024 Q1	$422K	Hold	2,700	–	–	0.08%	174
2023 Q4	$460K	Hold	2,700	–	–	0.23%	116
2023 Q3	$484K	Hold	2,700	–	–	0.1%	155
2023 Q2	$488K	Buy	+2,700	New	+$622K	0.11%	138
2021 Q1	–	Sell	-2,700	Closed	-$837K	–	329
2020 Q4	$837K	Hold	2,700	–	–	0.19%	97
2020 Q3	$825K	Buy	+2,700	New	+$635K	0.22%	93

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Sanders Morris Harris's ONC Position: Q2 2026 in Review

Sanders Morris Harris sold out of BeOne Medicines Ltd (ONC) in Q2 2026, closing a stake of 2,700 shares — an estimated $802K sold.

Sanders Morris Harris first reported a position in ONC in Q3 2020 and held it in 12 quarters. The position peaked at $920K in Q3 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Sanders Morris Harris reported no remaining BeOne Medicines Ltd position as of Q2 2026 after selling out during the quarter.
Sanders Morris Harris sold 2,700 BeOne Medicines Ltd shares in Q2 2026, an estimated $802K.
Sanders Morris Harris first reported a position in BeOne Medicines Ltd in Q3 2020 and held it in 12 quarters.
Sanders Morris Harris's BeOne Medicines Ltd position peaked at $920K in Q3 2025.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Sanders Morris Harris's 13F filing for Q2 2026, filed 7 Jul 2026.